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Abstract:  Research  on  diphtheria  and  anthrax  toxins  over  the  past  three  decades  has 
culminated  in  a  detailed  understanding  of  their  structure  function  relationships  (e.g., 
catalytic  (C),  transmembrane  (T),  and  receptor  binding  (R)  domains),  as  well  as  the 
identification of their eukaryotic cell surface receptor, an understanding of the molecular 
events  leading  to  the  receptor-mediated  internalization  of  the  toxin  into  an  endosomal 
compartment, and the pH triggered conformational changes required for pore formation in 
the  vesicle  membrane.  Recently,  a  major  research  effort  has  been  focused  on  the 
development of a detailed understanding of the molecular interactions between each of 
these  toxins  and  eukaryotic  cell  factors  that  play  an  essential  role  in  the  efficient 
translocation  of  their  respective  catalytic  domains  through  the  trans-endosomal  vesicle 
membrane pore and delivery into the cell cytosol. In this review, I shall focus on recent 
findings that have led to a more detailed understanding of the mechanism by which the 
diphtheria toxin catalytic domain is delivered to the eukaryotic cell cytosol. While much 
work remains, it is becoming increasingly clear that the entry process is facilitated by 
specific interactions with a number of cellular factors in an ordered sequential fashion. In 
addition,since diphtheria, anthrax lethal factor and anthrax edema factor all carry multiple 
coatomer I complex binding motifs and COPI complex has been shown to play an essential 
role in entry process, it is likely that the initial steps in catalytic domain entry of these 
divergent toxins follow a common mechanism. 
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1. Diphtheria Toxin and Diphtheria Toxin-Based Fusion Protein Toxins 
More than thirty years ago, A.M. Pappenheimer, Jr. [1] described diphtheria toxin as one of the 
most successfully studied of the bacterial protein toxins, and as a model system diphtheria served as a 
paradigm  for  the  analysis  of  the  other  protein  toxins.  With  recent  advances  in  understanding  the 
mechanism by which diphtheria toxin catalytic domain enters the eukaryotic cell cytosol, diphtheria as 
a model system has remained at the forefront and its study continues to provide key insights into 
eukaryotic cell protein::bacterial protein toxin interactions that are essential in the intoxication process. 
Diphtheria toxin is synthesized by toxigenic strains of Corynebacterium diphtheriae in precursor 
form  and following cleavage of its  25 amino  acid  signal  sequence, it is  released into the culture 
medium as a 535 amino acid single chain protein [2–4]. The ADP-ribosyltransferase activity of the 
toxin  is  activated  by  proteolytic  ―nicking‖  of  the  -carbon  backbone  at  Arg193  in  an  exposed  
14 amino acid loop formed by a disulfide bond between Cys186 and Cys201. Upon reduction under 
denaturing  conditions,  ―nicked‖  toxin  may  be  separated  into  a  21.1  kDa  N-terminal  polypeptide 
(residues 1–193), which contains the catalytic (C) domain, and a 41.2 kDa C-terminal polypeptide 
(residues  194  to  535),  which  carries  both  the  transmembrane  (T)  and  receptor  binding  (R)  
domains [5–8]. The C-domain catalyzes the NAD
+-dependent ADP-ribosylation of elongation factor 2 
(EF-2), the inhibition of cellular protein synthesis and ultimately cell death by apoptosis [8–10].  
Fragment B carries both the T-domain and the R-domain. The native R-domain (residues 432–535) 
mediates  the  binding  of  diphtheria  toxin  to  its  cell  surface  receptor,  a  heparin  binding  epidermal 
growth  factor  precursor  (hb-EGF)  [8,11].  In  1986,  Murphy  and  co-workers  pioneered  the  use  of 
diphtheria  toxin  as  a  structural  platform  to  genetically  construct  a  family  of  fusion  proteins 
toxins [12,13]. These chimeric toxins were constructed by the genetic deletion of the portion of the 
toxin structural gene encoding the native R-domain and its replacement with a synthetic gene encoding 
a surrogate receptor binding domain. The resulting fusion protein toxin is thereby directed to and 
selectively cytotoxic for only those target cells which express the appropriate targeted cell surface 
receptor. These fusion protein toxins have proved to be useful to probes in cell biology, in the study of 
the mechanism of toxin entry into the cytosol, and in one instance as a novel therapeutic which is now 
used  in  clinical  medicine.  DAB389IL-2  (ONTAK
®)  [14,15],  was  approved  in  1999  by  the  U.S. 
Food and  Drug  Administration  for  the  treatment  of  CD25  positive  refractory  cutaneous  T  cell 
lymphoma [16], and targets the recombinant fusion protein toxin to cells that display the high affinity  
IL-2 receptor. 
2. The Intoxication Process 
The intoxication of sensitive eukaryotic cells by diphtheria toxin follows an ordered series of events. 
As shown in Figure 1, the first step in the process is the binding of the toxin to its cell surface receptor 
the heparin binding epidermal growth factor-like precursor, hb-EGF [11]. This association may be 
enhanced by the diphtheria toxin receptor associated protein 27, DTRAP 27, which is the primate 
homologue of human CD9 [17]. Receptor bound toxin is concentrated in clathrin coated pits and 
internalized  into  clathrin  coated  vesicles  (CCVs),  which  are  then  converted  into  early  endosomal 
vesicles (EEVs) [18]. As the clathrin triskelon is  replaced with a new set of protein components, 
including Arf-1 and COPI complex, the activity of the vacuolar (v)ATPase lowers the luminal pH of Toxins 2011, 3                      
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the EEVs. It is widely known that the acidification of the vesicle lumen triggers the dynamic unfolding 
of the transmembrane domain (T) [19] which allows its insertion into the endosomal vesicle membrane 
forming a 18–22Å pore [20,21]. Pore formation is an essential prerequisite step for the translocation of 
the C-domain from the cis (luminal) to trans (cytosolic) side of the EEV membrane. While debate 
continues  over  the  precise  mechanism  and  requirements  for  this  translocation  event,  it  is  widely 
accepted that the formation of this cation selective membrane pore is a critical step, without which 
translocation of the C-domain cannot occur. We have hypothesized that the C-domain of diphtheria 
toxin is threaded through the pore by a process which is facilitated by a Cytosolic Translocation Factor 
(CTF) complex [22,23]. A second hypothesis has suggested that the nascent chaperone-like activity of 
the  partially  unfolded  T-domain  mediates  the  autonomous  delivery  of  the  C-domain  across  the 
membrane  [24,25].  In  either  case,  translocation  of  the  C-domain  is  followed  by  reduction  of  the 
disulfide bond between Fragments A and B, which results in the release of the C-domain into the 
cytoplasm. Once delivered into the cytosol, the C-domain is refolded into an enzymatically active 
conformation  and  catalyzes  the  NAD
+-dependent  ADP-ribosylation  of  elongation  factor  2  (EF-2), 
thereby inhibiting cellular protein synthesis. Upon cessation of protein synthesis the intoxicated cell 
will  ultimately  die  by  apoptosis  [10].  In  an  elegant  early  experiment,  Uchida  and  coworkers 
demonstrated that the introduction of a single molecule of fragment A is sufficient to cause the death 
of that cell [26]. 
Figure 1. Schematic depiction of the mechanism of diphtheria toxin entry into eukaryotic 
cell cytosol. (1) Diphtheria toxin binds to its cell surface receptor and is (2) internalized in 
clathrin coated pits into early endosomal vesicles. Upon acidification of the endosomal 
lumen,  (3)  the  transmembrane  domain  of  the  toxin  undergoes  a  spontaneous  dynamic 
reorganization  and  inserts  into  the  membrane  forming  a  pore  through  which  (4)  the  
C-domain is delivered to the cytosol. The delivery of the C-domain is facilitated by at least 
COPI  complex,  thioredoxin  reductase  and  Hsp90.  Once  refolded  into  an  active 
conformation,  the  C-domain  catalyzes  the  ADP-ribosylation  of  elongation  factor  2. 
Diphtheria toxin: red = catalytic domain; green = transmembrane domain; yellow = native 
receptor binding domain. 
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3. Pore Formation, Topography and Catalytic Domain Delivery  
In 1976, Boquet and coworkers [19] made the critical observation that CRM45, a chain termination 
mutant that lacks the native R-domain, and the Fragment B in denatured diphtheria toxin had the 
detergent-like  binding  properties  of  integral  membrane  proteins.  This  observation  led  these 
investigators to postulate that under low pH, the T-domain of diphtheria toxin undergoes a dynamic  
re-organization, allowing it to insert into the vesicle membrane and provide a portal of entry into the 
cytosol. Donovan et al. [20] then demonstrated that diphtheria toxin in acidic conditions was able to 
form  a  pore  in  artificial  lipid  bilayers,  a  finding  later  extended  by  Kagan  et  al.  [21]  and  
Deleers et al. [27], who suggested that a pH gradient was required to facilitate C-domain delivery. 
Shiver and Donovan [28], using asolectin vesicles, demonstrated that diphtheria toxin could deliver its 
own C-domain across the artificial bilayer in a pH dependent fashion, independent of added proteins or 
factors.  Interestingly,  these  studies  demonstrated  a  requirement  for  a  pH  gradient,  in  which  the 
endocytic vesicle luminal pH is optimally between 4.7 and 5.5 and the cytosolic pH is at or near 7.4. 
Once the X-ray structure of diphtheria toxin was solved, it was recognized that the acidic environment 
of endosomal lumen triggers the rearrangement of the T-domain of diphtheria toxin, residues 194–386, 
positioning  the  nine  transmembrane  helices  (TH-1  through  TH-9)  across  or  adjacent  to  the  
membrane [29]. The insertion of the -helical hairpin loop formed by TH-8 and TH-9 into the vesicle 
membrane is required to form a pore, and these helices may be stabilized by association with a second 
-helical hairpin loop formed by TH-5 and TH-6/TH-7 [30,31]. Assays used to measure the formation 
and conductance of membrane pores, such as patch clamp experiments, molecular marker exclusion 
studies,  and  pH  sensitive  dyes  have  been  used  in  conjunction  with  diphtheria  toxin  mutants  to 
demonstrate  the  importance  of  specific  residues  in  pore  formation  and  support  a  model  of  helix 
insertion as depicted below (Figure 2). 
The requirement for diphtheria toxin to pass through an acidic compartment in order to deliver its 
C-domain to the cytosol was established in a number of early studies, including the ability of weak 
bases and amines (e.g., ammonium salts, glutamine, chloroquine) [32] and ATP inhibitors to block  
C-domain delivery [33]. However, it was the use of specific v-ATPase inhibitors, such as Bafilomycin 
A-1 [34,35] that ultimately confirmed that pore forming activity was associated with the action of the 
v-ATPase in the endosomal vesicle membrane.  
The crystal structure of diphtheria toxin also allowed for the re-interpretation of earlier findings and 
the  generation  of  toxin  mutants  at  positions  implicated  in  translocation.  [36,37].  The  T-domain 
(residues 195–389) is comprised of three helical layers. Layer 1 contains helices TH-1, TH-2 and  
TH-3, which are amphipathic in nature. Helices TH-5, TH-6, and TH-7 are hydrophobic and make up 
the second layer, while the third helical layer is comprised of helices TH-8 and TH-9 and forms the 
central core of the T-domain. One approach used to understand the topography of membrane inserted 
diphtheria toxin has been to examine the sensitivity of either full length diphtheria toxin or fragment B 
to enzymatic cleavage in cell membranes or artificial bilayers [38]. Insertion of transmembrane helices 
8 and 9 is a common finding of these studies, however, discrepancies arise in interpreting cleavage 
products that include the C-domain and whether or not they represent translocation intermediates. For 
example, Madhus [39] and Madhus et al. [40] describe the observation of a 24–25 kDa Fragment A 
containing  protease  product  derived  from  cell  membrane  bound  N-ethylmaleimide  (NEM)  treated Toxins 2011, 3                      
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diphtheria toxin. One interpretation offered by these investigators is that this portion of the T-domain 
enters the cytosol and these findings suggest that sequences in TH-1 might be closely associated with 
C-domain residues and play a role in translocation. Further work by Madshus et al. [39] suggested the 
importance  of  TH-1  in  translocation  and  implied  possible  interactions  with  an  ―unidentified 
translocation apparatus‖, as will be discussed below. These early findings were prescient of recent 
work which has demonstrated the KXKXX COPI complex binding motifs in transmembrane helix 1 of 
the T-domain that are essential for catalytic domain delivery to the cytosol [41]. 
Figure 2. Schematic representation of the insertion of the diphtheria toxin transmembrane 
domain  into  the  endosomal  vesicle  membrane  which  results  in  the  formation  of  a 
transmembrane pore. Following furin mediated ―nicking‖ of the toxin after Arg194 and 
denaturation of the catalytic domain, the N-terminal portion of the transmembrane domain 
with  its  disulfide  bond  linked  C-terminal  end  of  the  catalytic  domain  appears  to  be 
threaded into the pore. Upon emergence of one or more of the KXKXX motifs on the 
cytosolic  side  of  the  vesicle  membrane,  COPI  complex  binds  to  these  sequences  and 
facilitates the translocation of the catalytic domain. 
 
As early as 1981, Donovan et al. [20] and Kagan et al. [21] estimated that the pore formed by the  
T-domain was sufficiently large (18–22 Å) to accommodate the transit of a fully denatured C-domain 
from  the  luminal  to  cytosolic  side  of  the  EEV  membrane.  Point  mutations  in  the  T-domain  of 
diphtheria  toxin  began  to  elucidate  residues  required  for  T-domain  refolding,  insertion  and  pore 
formation. Mindell et al. [42] and O’Keefe et al. [30] demonstrated the importance of residues Glu349 
and Asp352 in the loop connecting TH-8 and TH-9. This loop forms a hinge which facilitates the 
insertion of TH-8 and TH-9 into the vesicle membrane. vanderSpek et al. [43] demonstrated that, 
while pore formation is required for C-domain delivery to the cytosol, it is not in itself sufficient. 
While TH-8 and TH-9 alone can create a pore [44], the pore that is formed cannot affect C-domain Toxins 2011, 3                      
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delivery to the cytosol. Hu et al. [45] demonstrated that mutations in TH-5 and TH-6 results in pore 
competent but non-toxic mutant forms of the toxin. Similarly, mutations in TH-1, TH-2, and TH-3 
permitted the formation of intact pores, but resulted in mostly non-toxic mutants that retained full 
ribosyltransferase  activity.  Thus,  detailed  structural  functional  analysis  of  diphtheria  toxin  has 
characterized the cell binding, catalytic activity, and pore forming domains of diphtheria toxin, and has 
suggested that sequences between amino acid 194 and 280, including TH-1 through TH-4 may be 
involved in the translocation of the C-domain through the T-domain formed pore in the endosomal 
vesicle membrane. 
4. Autonomous vs. Facilitated Hypotheses of Diphtheria Toxin Catalytic Domain Delivery to the 
Cytosol 
The apparent ability of diphtheria toxin to transfer its C-domain across synthetic lipid bilayers in the 
absence of other proteins led to a model of autonomous C-domain delivery. London and colleagues [24] 
provided evidence that the diphtheria toxin T-domain, when partially inserted into membranes, can 
bind both its own C-domain as well as other proteins [46]. Using planar lipid membranes, Oh et al. [25] 
labeled diphtheria toxin with an N-terminal histidine tag (6×  His) and showed that the addition of Ni
2+ 
to the trans compartment prevented the rapid closure of pores. Based upon these observations, these 
investigators concluded that the 6×  His-tag and presumably the amino terminal end of the C-domain 
are translocated from the cis to the trans side of the lipid bilayer upon pore formation by the T-domain. 
Ren et al. [24] also showed that in a low pH environment the T-domain of diphtheria converts from a 
shallow  membrane-inserted  form  (capable  of  binding  the  C-domain)  to  a  fully  trans  inserted 
membrane form. Thus, in the autonomous translocation model, delivery of the C-domain is achieved 
through  the  chaperone-like  activity  of  the  T-domain  coincident  with  its  full  insertion  into  a  lipid 
membrane. It is noteworthy that the majority of the data to support this theory is derived from studies 
using artificial bilayers rather than the analysis of catalytic domain translocation across the endosomal 
vesicle membrane.  
While  diphtheria  toxin  may  posses  the  ability  to  utilize  a  pH  gradient  in  conjunction  with  a 
relatively high membrane potential to mediate a process of partial or even complete catalytic domain 
translocation in vitro, it is not at all clear that these conditions occur in vivo. Furthermore, numerous 
proteins decorate both the luminal and cytosolic face of endocytic vesicles, and a variety of membrane 
associated proteins  are  known to  serve as  mediators of endocytosis and vesicular trafficking,  and 
the potential  role  of  these  factors  cannot  be  examined  with  systems  that  employ  artificial 
membrane bilayers. 
It should be recognized that the potential requirement for cellular factors in the diphtheria toxin 
catalytic  domain  entry  process  was  postulated  as  early  as  1984  [47].  However,  it  was  not  until 
Lemichez et al. [48] and Ratts et al. [22] provided direct experimental evidence that cellular factors 
were essential for catalytic domain delivery to the cytosol that a hypothesis which proposed the direct 
participation of cellular factors in facilitating delivery was put forth. In this context, the requirement 
for receptor mediated endocytosis, and the findings that inhibitors of clathrin, dynamin, and (v)ATPase 
all  block  intoxication  by  diphtheria  toxin  all  relate  to  cellular  factors  that  are  essential,  but  act 
indirectly in the C-domain entry process [18,29,49]. Toxins 2011, 3                      
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Ground breaking work by Lemichez et al. [48] on the development of an in vitro translocation assay 
using partially purified early endosomes that were pre-loaded with diphtheria toxin provided the first 
direct evidence to support the notion that the delivery of the C-domain to the cytosol occurs from an 
early endosomal compartment, and that both ATP and cellular factors were essential for this to occur. 
Using this in vitro translocation assay system, Lemichez et al. [36] were also the first to recognize that 
C-domain translocation from the lumen of endosomal vesicles to the external medium requires the 
participation of at least -COP from the COPI complex. 
5. Partial Purification and Characterization of Cytosolic Factors Required for Diphtheria Toxin 
Translocation 
Ratts et al. [22] confirmed and extended the observations of Lemichez et al. [48] by the purification 
and identification of cellular factors that were essential for the in vitro translocation and release of the 
C-domain from the fusion protein toxin  DAB389IL-2 from pre-loaded partially purified endosomal 
vesicles. Using the in vitro translocation assay developed by Lemichez et al. [48] as a purification 
assay, Ratts et al. [22] were able to purify a Cytosolic Translocation Factor (CTF) complex from crude 
Hut102  cell  and  yeast  lysates  by  ca.  650-800-fold.  Following  mass  spectrometry  sequencing,  the 
potential role of individual proteins in the translocation process was examined through the use of 
specific inhibitors and/or neutralizing antibodies. For example, immunodepletion of either Hsp90 or 
thioredoxin reductase from crude lysates of either Hut102 cells or yeast eliminated the ability of these 
extracts  to  support  C-domain  translocation.  Whereas,  the  addition  of  recombinant  Hsp90  and/or 
thioredoxin reductase to either of the depleted extracts was found to restore C-domain translocation 
activity. Finally, in combination geldanamycin and radicicol, both specific inhibitors of Hsp90, and the 
addition  of  the  thioredoxin  reductase  stereo-specific  inhibitor  cis-13-retinoic  acid  to  the  reaction 
mixture were found to block C-domain translocation in vitro. 
6.  Interaction(s)  between  the  Diphtheria  Toxin  Transmembrane  Domain  Helix1  and  COPI 
Complex Proteins 
Since the results from  in vitro translocation experiments described above clearly suggested the 
direct participation of eukaryotic cell factors in the C-domain entry process, we reasoned that there 
might be conserved amino acid sequences in the data base whose identity could possibly lead to further 
insights into the C-domain entry process. Accordingly, Ratts et al. [23] conducted an in silico analysis 
of the primary amino acid sequence of diphtheria toxin that employed BLAST (Basic Local Alignment 
Search Tool) [50], and Clustal W alignment [51] analysis. In this approach overlapping 12 amino acid 
sequences from diphtheria toxin were used to probe the data base. Remarkably, a conserved 10 amino 
acid motif common to diphtheria toxin, anthrax lethal factor, anthrax edema factor and botulinum 
neurotoxins serotype A, C, and D was identified by the Multiple Expectation maximization for Motif 
Elucidation (MEME, [52]) computational search tool. This potential entry motif was designated T1, 
and in each instance the motif was positioned in a region of the toxin that was believed to emerge 
through the endosomal vesicle pore and into the cytosol early on in the entry process (Figure 3). Toxins 2011, 3                      
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Figure  3.  Partial  amino  acid  sequences  of  N-terminal  regions  of  the  diphtheria  toxin 
transmembrane  domain,  anthrax  lethal  factor,  and  anthrax  edema  factor  showing  the 
positions of their respective T1 or T1-like motifs and the clustering of multiple KXKXX 
COPI binding motifs on each protein. 
 
As described by Ratts et al. [23], two lines of evidence provide support for the idea that the T1 
motif and adjacent amino acid residues play an essential role in the entry process. Stable transgenic 
Hut102 cells that express a mini-gene encoding the T1 motif corresponding to amino acids 210–229 of 
diphtheria toxin become >1000-fold more resistant to DAB389IL-2 challenge than that parental cell line. 
Moreover,  when  transgenic  Hut102  cells  were  co-transformed  with  an  siRNA  expression  vector 
designed to suppress the expression of the T1 motif containing peptide, the sensitivity of these cells to 
DAB389IL-2 returned to that of the parental cell line (IC50 = ~7 ×  10
−11 M) [23]. Based upon these 
observations, we reasoned that the protection afforded by T1 peptide expression was likely due to the 
peptide blocking an essential protein::protein interaction at a step in the C-domain entry process. 
In an attempt to demonstrate such an interaction, a fusion protein was constructed between GST and 
a peptide that carried the T1-motif. This fusion protein was then used as bait in a series of pull down 
experiments with crude eukaryotic cell lysates. Both GST and the GST-DT140-271 fusion protein 
were used to adsorb proteins from post nuclear extracts of HUT102/6TG cells. A number of T-domain 
specific  proteins  were  eluted  with  the  GST-DT140-271  fusion  protein  and  identified  by  mass 
spectroscopy. This analysis resulted in the identification of -COP by immunoblot analysis [23]. Using 
labeled  [
35S]-β-COP  that  was  synthesized  in  vitro  using  a  rabbit  reticulocyte  transcription  and 
translation reaction mixture, we found that GST-DT140-271 not only specifically bound and pulled 
down [
35S]-β-COP, but that this interaction could be inhibited by the addition of increasing amounts of 
synthetic T1-motif peptide to the reaction mixture. While these observations confirmed and extended 
those of Lemichez et al. [48], they also suggested that the interactions between at least -COP and the 
toxin were likely to be direct.  
It is well known that COPI is a heptameric structure that is composed of ʱ-, β-, β'-, γ-, ε-, δ-,  
δ-subunits, and the cellular functions of the complex is to facilitate endosomal vesicular trafficking and 
the retrograde transport of vesicles between Golgi compartments, and between the Golgi apparatus and 
the endoplasmic reticulum [53–55]. In this process, COPI complexes are recruited to the cytosolic 
surface of vesicle membranes en bloc by Arf-GTP [56,57]. Once bound to the membrane surface, Toxins 2011, 3                      
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secondary interactions between COPI and the cytoplasmic tails of cargo proteins and p23/24 adaptor 
proteins further stabilize its binding to the membrane surface. This secondary binding is mediated 
between dibasic signatures (KKXX, KXKXX) and/or aromatic amino acid signatures [FFXXBB(X)n] 
in cargo and p23/24 adaptor proteins and individual subunits of the COPI complex [58–60]. 
The presence of multiple KXKXX motifs in the T1-moif and its adjacent amino acids (Figure 3) 
and the emergence of these sequences on the cytosolic surface of the endosomal vesicle membrane 
raised the possibility that this region of the transmembrane domain could function as a mimetic of the 
cytoplasmic tail regions of either the cargo or p23/24 adaptor proteins and facilitate COPI binding. 
Trujillo et al. [61] tested this hypothesis by undertaking an analysis of helix 1 of the T-domain by  
site-directed  mutagenesis  and  COPI  binding  domain  swap  mutagenesis.  This  analysis  has  clearly 
demonstrated that at least three of the four lysine residues in the region of the T1 motif are required for 
both COPI binding and for cytotoxic activity of DAB389IL-2.  
Hudson and Draper [61] previously demonstrated that at lest two pairs of closely positioned amino 
moieties in neomycin were required to cross-link and induce precipitation of COPI complex in vitro. 
Trujillo et al. [41] also described a series of experiments in which synthetic peptides whose sequences 
were related to transmembrane helix 1 of diphtheria toxin were used to examine COPI cross-linking 
and precipitation. As was previously demonstrated with neomycin, two pairs of dilysine residues in 
these peptides were required to induce binding and precipitation of COPI. Since the addition of the 
monoamine 1,3-cyclohexanebis(methylamine), CBM, to the reaction mixture blocked peptide binding 
to COPI complex, Trujillo et al. [41] reasoned that, as in the case of neomycin and the cytoplasmic 
tails of both cargo and p23/24 adaptor proteins, the interaction between transmembrane helix 1 and 
coatomer I was mediated through -amino moieties on the peptides.  
Perhaps, the most compelling data supporting the essential role of COPI binding to the T1 motif and 
adjacent lysine residues in transmembrane helix 1 in the C-domain entry process comes from the 
domain swap experiments reported by Trujillo et al. [41]. In this instance, the 13 amino acid COPI 
binding sequence from the cytoplasmic tail region of the p23 adaptor protein was used to replace the 
native  T1  motif  and  adjacent  upstream  lysine  residues  in  DAB389IL-2.  Following  it  construction, 
expression and purification the COPI domain swap mutant DAB(212p23)389IL-2 was examined for 
cytotoxic activity against Hut102 cells in vitro. Dose response analysis clearly demonstrated that the 
domain swap mutant retained full cytotoxic potency (IC50 ≤ 5 ×  10
−11 M) relative to the ―wild type‖ 
fusion protein toxin. These results suggest that regardless of primary sequence, the primary role for 
this  region  of  the  transmembrane  helix  1  is  COPI  complex  binding  and  that  this  protein::protein 
interaction is essential for the delivery of the C-domain to the eukaryotic cell cytosol.  
The in silico analysis of the diphtheria toxin by Ratts et al. [49] revealed the presence of T1-like 
motifs  in  anthrax  lethal  factor.  Based  upon  this  analysis,  Tamayo  et  al.  [62]  used  an  in  vitro 
translocation assay similar to that used by both Ratts et al. [48] and Lemichez et al. [47] to investigate 
the requirements for lethal factor delivery from the endosomal lumen to the external medium. This 
analysis clearly demonstrated, that like diphtheria toxin, anthrax lethal translocation requires COPI 
complex. Moreover, like diphtheria toxin, anthrax lethal factor must be completely denatured in the 
endosomal  lumen  before  it  can  pass  through  the  membrane  pore  formed  by  Protective  Antigen. 
Furthermore, like the diphtheria toxin catalytic domain, this denaturation process was assumed to be 
triggered by the low pH environment in the lumen.  Toxins 2011, 3                      
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In  the  current  working  model  of  diphtheria  toxin  C-domain  entry  (Figure  1),  we  envision  the 
cytosolic  delivery  process  to  occur  as  follows:  following  binding  of  the  toxin  to  its  cell  surface 
receptor and internalization into an endosomal compartment, it has been long assumed that in the 
acidic environment of the early endosome the catalytic domain becomes completely unfolded, it now 
appears as though the C-terminal end of the catalytic domain along with its disulfide bond linked  
N-terminal end of the transmembrane domain are treaded into the transmembrane pore. While the 
precise nature of the denaturation and threading remain to be fully worked out, recent preliminary 
observations with anthrax LFnDTA and LF suggest that cellular factors may also participate in this 
process as well. Nonetheless, once the multiple KXKXX sequences in transmembrane helix 1 and 2 
pass through the pore and are presented on the cytosolic face of the endosomal vesicle, they appear to 
be recognized as either cargo and/or p23/24 cytoplasmic tail mimetics and, as such, serve as targets for 
COPI complex binding. It is likely that this toxin::COPI complex would be transiently stabilized on the 
cytosolic surface of the vesicle membrane through additional interactions between COPI complex and 
Arf-GTP. However, upon conversion of Arf-GTP to Arf-GDP a binary complex composed of COPI 
complex and the N-terminal portion of the T-domain would be released from the membrane surface.  
It is known that COPI complex interactions with the cytoplasmic tails of either cargo or p23/24 
adaptor  proteins  which  are  anchored  in  the  membrane  effect  vesicle  trafficking  in  the  cytosol. 
However, in marked contrast to cargo and adaptor proteins, the fully denatured catalytic domain along 
with its disulfide bind linked N-terminal portion of the transmembrane domain (e.g., transmembrane 
helices 1–4) are not involved in the formation of the pore. Since this portion of the transmembrane 
domain appears to be un-tethered, association with COPI complex may allow transmembrane helices 
1–4 and the carboxy-terminal region of the catalytic domain to be ―pulled‖ through the pore which is 
formed by transmembrane helices 5 through 9—much like a string may be pulled through a ring.  
Ratts et al. [48] have previously demonstrated that cytoplasmic thioredoxin reductase is essential for 
the translocation and release of the C-domain in vitro, and Hsp90 (and possibly Hsc70) most likely 
serve as a ―refoldase‖ to generate its ADP-ribosyltransferase activity. It is of interest to note that 
Hsp90 also has been shown to be essential for the either the translocation or refolding of Clostruidium 
botulinum C2 toxin into the eukaryotic cell cytosol [62,63], the transfer of the A1 subunit of cholera 
toxin from the endoplasmic reticulum to the cytosol [64], and the cytosolic delivery of the anthrax 
related fusion protein LFnDTA [65].  
While much work remains, it is now apparent that the molecular mechanism of diphtheria toxin 
catalytic domain entry into the eukaryotic cell cytosol is facilitated by target cell proteins, all acting in 
a systematic and ordered fashion in the delivery process.  
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